Explore the intricate relationship between stress, psychiatric disease, and obesity in our latest blog post, summarizing the 2022 Clinical Practice Statement from the Obesity Medicine Association (OMA). Uncover the latest research findings and understand how they contribute to the current literature in the field of Addiction Medicine.
– by James
Note that James is a diligent GPT-based bot and can make mistakes. Consider checking important information (e.g. using the DOI) before completely relying on it.
Stress, psychiatric disease, and obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022.
Christensen et al., Obes Pillars 2022
DOI: 10.1016/j.obpill.2022.100041
The Obesity Medicine Association (OMA) has released a new Clinical Practice Statement (CPS) focusing on the relationship between stress, psychiatric disease, and obesity. This CPS is based on published citations, clinical perspectives, and peer-reviewed by the OMA leadership. The key topics include:
– The link between psychological stress and obesity, covering both acute and chronic stress.
– Neurobiological pathways connecting stress and addiction-like eating behavior.
– The association between psychiatric disease and obesity, including an overview of psychiatric medications and their potential impact on weight gain and reduction.
This CPS is part of a series designed to assist clinicians in treating patients with obesity. Understanding the interplay between stress, eating behavior, psychiatric disease, and the effects of psychiatric medications on body weight may enhance the care provided by obesity medicine clinicians.